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One in four people attempting to conceive will experience infertility. The current 
theory is that infertility is caused by a decreased number and quality of eggs in the 
ovary. However, ovarian aging cannot be the sole cause of infertility. In natural 
conception, the first days of embryonic growth occur within the oviduct. In IVF, this 
growth period occurs in the lab, eliminating the oviduct's effect on the embryo. 
Previously the role of the oviduct has not been questioned. The difference of 
embryos reaching the blastocyst stage between young and aged mice was 
quantified to establish the extent of the preimplantation loss. To investigate the level 
of expression of growth promoters and inhibitors in the oviducts of aged and young 
mice during pregnancy, RT-qPCR was completed. Additionally, spectral cytometry 
was used to investigate if a change in the Treg cell population occurred with 
advancing maternal age. This study showed that the number of embryos surviving to 
the blastocyst stage was significantly decreased in aged mice. No difference was 
identified between young and aged mice and the expression of embryo growth-
promoting or inhibiting factors within the oviduct. This study concluded that there 
were no changes in the presence of T regulatory cells with advancing maternal age. 
Our results showed that preimplantation loss is increased in aged mice compared to 
young mice due to a post-ovulatory effect. We confirmed that the increase in 
preimplantation loss is not due to a change in the expression of growth promoters or 
inhibitors within the oviduct. Nor is it due to a change in the response of the maternal 
inflammatory system to pregnancy. We postulate that an increase in abnormal eggs 
within the ovary is occurring with advancing maternal age, and is resulting in an 
increased number of aneuploidy embryos degrading before implantation.  
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1 Introduction  
1.1 Overview  
Females have a short window in which they can reproduce successfully, as fertility 
declines rapidly with age. In Vitro Fertilisation (IVF) is the method of assisted 
reproduction that aims to treat infertility. However, IVF success rates remain below 
30% and steadily decrease with advancing age (Gleicher et al., 2019). IVF has not 
evolved to increase the success rates since its introduction in 1970. Thus, IVF fails 
to deliver the quality of treatment required for the current increasing rates of female 
age-related infertility. Most research concerning the age-related decline in fertility 
focuses on the ovaries and the uterus (Mikwar et al., 2020; Woods et al., 2017). 
Alternative theories of reproductive decline need to be considered, such as the 
critical tissue influencing early embryogenesis, the oviducts. Early embryogenesis in 
natural conception relies on the micro-environment of the oviduct and the response 
of the maternal inflammatory system. Within the oviduct, the embryo will undergo 
rapid divisions from a one-cell embryo to a blastocyst in the first few days of 
pregnancy. The embryo relies on communication from the oviducts to grow and 
survive. IVF has eliminated this communication via collecting eggs directly from the 
ovary, fertilising the eggs in a laboratory, and transferring the blastocyst into the 
uterus for implantation (Steptoe & Edwards, 1978). On account of this, research 
concerning how age affects the oviductal support of embryo growth and survivability 
is limited. Therefore, we do not currently know if the age of an oviduct negatively 
affects preimplantation embryo development. Furthermore, we also do not know if 
the immune response within the oviduct contributes to the age-related decline in 
female fertility. Understanding the consequences of ageing and the immune 
response within the oviduct is vital to further the current knowledge on the aetiology 
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of the age-related fertility decline. This also provides a possible novel target for 
infertility treatment. 
1.2 Age and infertility  
1.2.1 Age related decline in female fertility   
Fertility naturally declines as females increase in age. Clinically, infertility is defined 
as a disease identified by a failure to establish a clinical pregnancy after 12 months 
of regular unprotected sex or due to an impairment of a person’s ability to reproduce 
(Zegers-Hochschild et al., 2017). Fecundability is the probability of achieving 
pregnancy per menstrual cycle in a couple attempting to conceive. Peak female 
fecundability occurs between 27 and 30 years of age and is followed by a decline 
from the age of 30 onwards (Rothman et al., 2013). The standard marker of loss of 
fertility in females is the reduction of oestrogen production by the decreasing number 
of eggs present in the ovaries (Faddy et al., 1992). This marks the end of menarche 
and the beginning of menopause. However, infertility has been reported to 
commence years before the onset of menopause (Dólleman et al., 2013). Mice have 
a similar profile of reproductive decline that occurs in a shorter period. Mice become 
reproductively active at 2 months old and will have a cycle length of 4-5 days, with a 
gestational period of 21 days (Vom Saal & Finch, 1988). The loss of infertility has 
been previously described for the mouse colony used in this study. Peak female 
fertility was reported at 6 months old in C57BL/6 wild type mice (Guo & Pankhurst, 
2020). Fertility gradually declined in mice aged 6 months old and above, with a steep 
decrease in litter size occurring at 10 months of age (Guo & Pankhurst, 2020). 
Therefore, mice are an appropriate animal model to study the age-related fertility 
decline in humans as they both exhibit loss of fertility with increasing age.  
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1.3  Is IVF a quick fix for age related infertility?  
1.3.1 Understanding the steps of IVF  
IVF involves growing artificially fertilised embryos within a laboratory environment. 
IVF beings with the aspiration of mature oocytes from the ovary (Steptoe & Edwards, 
1978). Eggs are collected via aspiration with the use of an ultrasound-guided needle. 
Often an IVF cycle begins with the hyperstimulation of ovaries through a combination 
of drugs such as follicle stimulating hormone (FSH) and gonadotropic releasing 
hormone (GnRH). FSH drugs are administered to mature more than one egg and 
promote poly-ovulation, whereas GnRH inhibits a premature luteinizing hormone 
surge to avoid spontaneous ovulation (Arce et al., 2014; Huirne et al., 2005). 
Hyperstimulation is used in the clinic to increase the number of mature eggs 
collected and thus the number of embryos transferred into the uterus in subsequent 
cycles. The oocytes are mixed with pre-prepared sperm, and embryos are incubated 
for approximately 5 days (Steptoe & Edwards, 1978). The blastocyst is then 
transferred into a uterus. IVF is the simplest of modern-day in vitro fertility treatments 
and involves four stages, gonadotropin stimulation, oocyte collection, fertilisation, 
and embryo transfer.  
1.3.2 Ovarian aging 
Depletion of the ovarian reserve in egg number and quality is hypothesised to be the 
cause of infertility in ageing women. The ovarian reserve is defined as the functional 
potential of the ovary and indicates the number of the oocytes present (Maheshwari 
et al., 2006). A female is born with a finite amount of germ cells. Developing follicles 
are recruited each cycle but only one will mature enough to ovulate, those that fail to 
respond to hormonal signals and do not ovulate will undergo follicle atresia resulting 
in subsequent oocyte loss (Vaskivuo et al., 2001). Therefore, as a female 
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experiences loss of oocytes, which will increase with advancing age, the ovarian 
reserve decreases (Hansen et al., 2008; Leidy et al., 1998). The exhaustion of the 
oocyte pool and ovarian function occurs approximately at age 51 and is known as 
menopause (McKinlay, 1985). However, population studies have shown that the 
decline of female fertility begins at 25 and becomes predominant at 40 years of age 
(Hull et al., 1985). So, infertility occurs approximately 11 years before the exhaustion 
of the ovarian reserve in humans. Ovarian reserve depletion is present in C57BL/6 
mice. At 11 months old, mice are near the end of their reproductive lifespan (Lopes 
et al., 2009). Interestingly, advancing maternal age in mice has not been reported to 
affect the number of eggs ovulated per cycle represented through the number of 
corpora lutea (Harman & Talbert, 1970; Ishikawa & Endo, 1996; Lopes et al., 2009). 
While egg count is diminishing in mice, it appears that the lack of eggs cannot be the 
sole cause of infertility, as aged mice are reported to ovulate the same number of 
eggs as young mice. While egg count has been thoroughly studied, there appear to 
be discrepancies between how large of an effect it has on the onset of infertility.  
1.3.3 Declining oocyte quality  
The incidence of aneuploidy increases with maternal age and is a second theory 
explaining why the ovary is the cause of the age-related fertility decline. Aneuploidy 
is defined as containing an abnormal number of chromosomes. Aneuploidy eggs are 
often responsible for missed abortions, early pregnancy loss, and congenital birth 
defects. In a female’s twenties, approximately 20-27% of their eggs are aneuploid, 
and this increases to approximately 55% by the age of 40 (Demko et al., 2016). An 
increase in abnormal eggs within the murine species has also been reported. In 
young mice, 10% of ovulated eggs were aneuploidy compared to 37% in aged mice 
(Fu et al., 2014).  Unlike humans, mice have an energy-saving mechanism to 
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reabsorb any embryo that shows low survivability. Resportion of embryonic tissue 
has been reported to be triggered through embryonic apoptosis markers and occurs 
between days 7 and 12 of murine development (Drews et al., 2020). This is an 
inflammatory response modulated by macrophages. Interestingly in 10-month-old 
mice, 85.6% of reabsorbed embryos were euploid (Tao & Liu, 2015). This suggests 
aneuploidy is not contributing to the majority of the age-related reproductive decline. 
An increase in abnormal eggs with age cannot be the only cause of the age-related 
decline in fertility, as below half of the eggs are abnormal in the murine ovaries at the 
time of reproductive decline.  
1.3.4 Uterine ageing  
Research concerning the aging process of the uterus is severely limited. However, of 
the research available, a breakdown in communication between the uterine tissue 
and embryo at the time of implantation has been reported. Similar implantation rates 
between women under and above 40 years of age have been reported. However, 
those above 40 experienced a significantly higher natural abortion rate post-
implantation (Sekhon et al., 2015). This observation has also been made in C57BL/6 
mice where the uterus decidualisation response to pregnancy in older mice is 
affected, which negatively influenced post-implantation growth (Woods et al., 2017). 
The number of implantation sites was reported to not differ between young and aged 
mice but, a 10-fold increase in resorption sites was identified in the aged females 
(Lopes et al., 2009). However, historically mice aged 10-11 months were reported to 
have a significant decrease in the number of implantation sites that continually 
decreased to the age of 14-15 months (Harman & Talbert, 1970). The current theory 
explaining uterine ageing reports that the effect of age is the breakdown of 
communication between the uterus and the embryo. However, there are 
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contradictions to this research, and therefore further studies must be undertaken to 
further our knowledge of the aging uterus.  
1.3.5 What is the cause of success of IVF?  
The cause of the success of IVF remains unknown. The leading theory within the 
research suggests that it is due to hyperstimulation of the ovaries. This is due to the 
multiple mature oocytes that are collected, resulting in the chance of more 
blastocysts to be transferred into the uterus (Nelson et al., 2009).  However, the 
research remains ambiguous surrounding this statement since infertility progresses 
before ovarian reserve exhaustion occurs (Demko et al., 2016; Hull et al., 1985). 
While IVF is successful under 30 years old, egg collection rate, successful 
implantations, and pregnancy rate decrease in those over 40 years old in IVF 
programmes (Tan et al., 2014). Therefore, the current infertility treatment is 
unsuccessful in the majority of age-related fertility decline cases. With over two 
decades of effort and research dedicated to improving IVF, it is surprising IVF live 
birth rates have not increased. It has been reported that IVF success rates have 
increased approximately 8%, from 16% to 22%, since the introduction of IVF 
(Gleicher et al., 2019). With the lack of increase in success rates and unsuitable 






1.4  The oviducts  
1.4.1 Anatomy of the oviducts  
The oviduct houses developing embryos during the first stages of development, 
classed as embryogenesis. In humans, the oviducts connect the ovaries and the 
uterus via their tubular structure (figure 1.1a) (Fuster et al., 2018). The oviduct 
contains three distinct sections the infundibulum, the ampulla, and the isthmus. The 
infundibulum is close to the ovary and extends fimbriae to pick up the ovulated 
oocyte from the ovary (Fuster et al., 2018). The ovulated oocyte is transported to the 
ampulla for fertilisation. The embryo will then move to the isthmus before descending 
to the uterus for implantation (Fuster et al., 2018). The epithelial layer of the oviduct 
contains secretory and multiciliated cells that aid the growth and transport of the 
embryo (Li et al., 2017). The murine reproductive tract differs from humans but 
contains the same components. The murine oviducts are coiled structures that are 
not directly connected to the ovary (figure 1.1a & b) (Rendi et al., 2012). Murine 
ovaries and the infundibulum of the oviduct are enclosed by a transparent bursa 
(Rendi et al., 2012). The bursa functions to pick up multiple ovulated oocytes and 
move them into the ampulla of the oviducts (figure 1.1b) (Rendi et al., 2012).  The 
two coiled structures feed into a bicornate uterus (Rendi et al., 2012). The epithelial 
cells of the murine oviduct have a high similarity with human epithelial cells. While 
the murine anatomy is not a replica of the human anatomy, the epithelial cell types 
and functions are an appropriate model for human reproduction.
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Figure 1.1 The difference between the human and murine oviduct.  (a) Schematic of human reproductive tract compared to mouse 
reproductive tract. Created with BioRender.com. (b) Image of an oviduct from a super ovulated female mouse with a copulatory 
plug, white arrow indicates the swollen ampulla, error bar measures 500µm.  
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1.4.2 How does the oviduct support pregnancy? 
The oviduct is required to provide a supportive environment to promote the 
survivability of embryos. The current research on the oviducts role in pregnancy 
focusses on the ability of the oviducts to support fertilisation. Oviductal fluid has been 
reported to promote sperm maturation and higher rates of fertilisation (Coy et al., 
2010; El-Shahat et al., 2018). One of the theories explaining this is the presence of 
proteins found in the oviduct fluid. Proteins within the fluid have been reported to 
increase sperm viability and motility. The oviduct also contains proteoglycans 
reported to promote capacitation of sperm which is essential for fertilisation (Lapointe 
& Bilodeau, 2003; Lenz et al., 1982). A decreased inflammatory response at the 
ampulla of the oviduct has also been reported as a mechanism of the oviduct to 
support fertilisation. An increased number of neutrophils was identified in the ampulla 
during ovulation this has been reported to suppress the female maternal 
inflammatory response against the foreign paternal antibodies and therefore promote 
fertilisation (Yousef et al., 2019). The current literature demonstrates that the oviduct 
is able to respond to sperm to support fertilisation and thus pregnancy.  
1.5  Oviduct and embryo interactions  
1.5.1 Embryo to oviduct communication  
Embryos send signals during early embryogenesis, which will bind the corresponding 
receptors expressed on the oviducts. The leading theory is that the embryo silences 
the maternal inflammatory response, allowing the embryo to survive until 
implantation. Evidence for embryos driving change within the bovine oviduct was 
identified when six differentially-expressed genes were found in oviducts exposed to 
embryos (K.-F. Lee et al., 2002). A follow-up study discovered that these 
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differentially-expressed genes varied in function and included cell-surface and cell-
cell interaction proteins and immune-related proteins (Bauersachs et al., 2003). RNA 
sequencing later revealed that 123 upregulated and 155 down-regulated genes were 
present in bovine oviducts exposed to multiple embryos (Maillo et al., 2015). The 
majority of the down-regulated genes were associated with the maternal immune 
response; this finding was also reported in pigs (Almiñana et al., 2012; Maillo et al., 
2015). Lefty2, a negative regulator of TGF-β cytokines, was exclusively upregulated 
in day-four pregnant rat oviducts suggesting its biological importance in silencing the 
maternal immune system (Argañaraz et al., 2012). The literature has confirmed that 
communication from the embryo to the oviduct is present during early pregnancy and 
is likely vital for the embryo’s survival.  
1.5.2 Oviduct to embryo communication  
Communication signals from the oviduct to the embryo to promote and inhibit growth 
have also been identified in early pregnancy. The oviducts release exosomes that 
contain growth factors into the oviduct fluid (Almiñana et al., 2017). An increasing 
number of studies have shown that these growth factors can influence embryo 
survival (Alan & Liman, 2021; S. H. Lee et al., 2020; Pillai et al., 2017). Growth 
factors that stimulate embryo growth have been identified using in vitro experiments. 
Embryo development is improved in culture media that contains growth factors such 
as transforming growth factor-beta (TGFB), epidermal growth factor (EGF), insulin-
like growth factor 1 (IGF-1), and the fibroblast growth factor family (FGF) (Dı́az-
Cueto & Gerton, 2001). Through RNA sequencing on the oviduct fluid, these growth 
factors have been identified in the oviduct (Wiseman et al., 1992). There are also 
growth factors present in the oviduct that inhibit embryo growth, including tumor 
necrosis factor (TNF) and colony-stimulating factor 2 (CSF-2) (Wuu et al., 1999). The 
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function of the inhibitory growth factors remains unclear. However, one theory 
suggests that cytokines inhibit the growth of less capable embryos, therefore, acting 
as a tool to select for survival only of high-quality embryos. In yak-cattle crossbred 
embryos, the blastocyst development rate increased 38% when EGF was 
supplemented into in vitro media (Yang et al., 2019). However,  in a similar study 
investigating bovine embryos, EGF had no beneficial effects on the embryos’ ability 
to reach the blastocyst stage (Flood et al., 1993). It is not clear whether species or 
methodological differences explain these inconsistent findings.  
 
TNF is an embryotoxic inflammatory cytokine solely produced by the maternal 
tissues and negatively affects embryo development (Hunt, 1993).  The addition of 
TNF to embryo culture media decreased the blastocyst development rate and 
increased the percentage of apoptosis markers within the blastomeres (Głabowski et 
al., 2005; Soto et al., 2003). In a second experiment, embryos were cultured with 
TNF and one of the following growth-promoting factors, EGF, IGF-1, IGF-II, or SCF, 
which improved blastocyst development (Głabowski et al., 2005). Therefore in this 
study, growth-promoting factors such as EGF were protective against the negative 
influence of TNF.  
 
Oviduct-derived growth factors have been shown to have an essential role in 
determining embryo development. The leading theory is that a delicate balance 
between growth-promoting and growth-inhibiting factors is required for healthy 
embryos to develop. However, research on growth factors in vivo remains 
ambiguous, with most results being produced from embryo in vitro cultures only.  
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1.6  Current knowledge of ageing oviducts  
1.6.1 Morphological changes with age  
Age-related morphological changes within tissue are associated with alterations in 
the extracellular matrix. These morphological changes have been shown to result in 
increased stiffness and loss of elasticity. There is a lack of research considering the 
morphological changes that occur in the aged oviduct. However, collagen production 
within the oviducts during the second half of the 5th decade of human life has been 
reported to accelerate, leading to rigid oviducts (Schultka et al., 1986).  A genetic 
study completed on post-ovulatory bovine oviduct epithelial cells concluded that 
there was a decrease by 14-fold in the expression of the collagen encoding gene, 
COL1A1, in aged cells compared to young cells (Tanaka et al., 2016). The 
consequence of collagen deposition in the oviducts is unknown, but it results in 
increased stiffness and loss of elasticity in the skin (Egbert et al., 2014; Varani et al., 
2006). While the direct cause of age-related stiffness in tissue remains ambiguous, 
the literature confirms that tissue rigidity in older age is likely due to changes in the 
extracellular matrix.  
1.6.2 Changes in function  
The leading explanation for the age-related decrease in fertility is a reduction in egg 
number and egg quality, but the possibility that the ageing oviduct has a reduced 
ability to support embryo development is rarely considered. Oviduct influences 
derived from aged oviduct epithelial cells (OEC’s) have been reported to contribute 
to the inferior development of embryos (Brinsko et al., 1994). Young mare embryos 
grown on oviduct epithelial cell cultures from old mares have delayed development 
to young mare embryos grown on young mare oviduct epithelial cells (Brinsko et al., 
1994) (figure 1.2). Therefore, older OEC’s have a negative influence on embryonic 
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growth, and thus age affects the ability of the oviduct to create an optimal 
environment. A potential mechanism could relate to reactive oxygen species (ROS), 
which accumulate with ageing in the oviduct and leads to cellular senescence and 
dysfunction (Tanaka et al., 2016). Another contributing factor could be the 
dysfunctional calcium signalling in aged oviducts leading to a breakdown in gap 
junctions which is essential for OEC function (Yan et al., 2011). Since the discovery 
of the negative signal from the aged oviduct cells by Steven Brinsko, no further 
research has been undertaken to discover what this negative signal may be (Brinsko 


































Figure 1.2 Age of oviduct epithelial cells effects the development of blastocysts. Image adapted from the results of (Brinsko et al., 





1.6.3 Is the oviduct a contributing factor of the age-related decline in females?  
IVF removes the eggs directly from the ovary, and instead of the first stages of 
embryogenesis occurring within the oviduct, embryogenesis occurs in a culture dish 
during IVF (figure 1.3). The artificially fertilised and grown embryo is then transferred 
directly into the uterus (figure 1.3). Therefore, IVF circumvents the oviduct and 
prevents exposure of the embryos to the oviduct-derived growth factors. In the 
current literature, it has not been questioned whether growing the embryos outside of 
the ageing oviduct removes a negative effect on the embryos and thus contributes to 

















Figure 1.3 Comparison of early embryo development in natural conception versus 
IVF. Natural embryonic development begins with the ovulation of oocytes from the 
ovary. Oocytes are fertilised at the site of the ampulla. The embryo will travel through 
the fallopian tube down to the site of implantation, the fundus of the uterus. In 
contrast, IVF aspirates the oocytes from the ovary, oocytes will be fertilised and 
grown under in vitro conditions. The embryo is then transferred into the uterus. 
Created with BioRender.com 
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1.7 Inflammatory systems role in establishing early pregnancy 
1.7.1 Function of T regulatory cells and the constituents they regulate  
T regulatory cells are a type of T cell that function to silence the inflammatory 
response. T cells are split into two subsets, cytotoxic T cells, which express CD8+, 
and T helper cells which express CD4+. CD4+ T cells are further defined by the 
signalling molecules, cytokines, they express. T cells are split into subsets of T 
helper cells such as Th1, Th2, and Th17, which upregulate the inflammatory 
responses when presented with foreign antigens. Regulatory T cells express either 
CD4+ and CD8+; however, much more is known about CD4+ Treg cells. CD4+ Treg 
cells can be identified through the expression of CD4+, CD25+, and Foxp3+. Treg 
cells have the opposite effect of T helper cells and silence the immune response 
(Gershon et al., 1972). Two pathways of Treg cells exist, natural Treg cells that are 
generated within the thymus (Shevach, 2002). Secondly, inducible Treg cells, that 
exist in peripheral tissues and will express receptors for antigens specific to the 
peripheral tissues (Shevach, 2002). Treg cells can silence effector T cells through 
multiple mechanisms, including contact dependant communication and cytokine 
deprivation (Takahashi et al., 1998). Treg cells secrete IL-10 and TGFB, which are 
reported to be the primary suppressive mediators of inflammation. However, in vitro 
studies have revealed that IL-10 and TGFB may not be essential for Treg function  
(Takahashi et al., 1998). Treg cells have also been reported to function by depriving 
T cells of the IL-2 cytokine they need to survive (Rosa et al., 2004). Treg cells 
directly silence T helper cells; however, reports of Treg cells mediating dendritic cell 
maturation and antigen-presenting function have been made (Tadokoro et al., 2006). 
Many claims have been made concerning Treg cell functional mechanisms; 
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however, many of these mechanisms appear to be redundant. This suggests that 
more research is required to determine the mechanisms Treg cells use to function.  
1.7.2 Treg cells in the establishment of pregnancy in conjunction with age 
related fertility decline  
The maternal immune response needs to be silenced during early pregnancy for the 
survival of an embryo. The maternal immune response is activated when the 
antigen-presenting cells present the foreign paternal antigens from the semen and 
embryo to the maternal immune cells (figure 1.4) (Erlebacher et al., 2007). Tregs are 
responsible for the silencing of the immune response triggered by the semi-allogenic 
embryo. An increase in Treg cell percentage has been identified in blood samples 
taken from early pregnancy stage females (Sasaki et al., 2004).  This increase has 
also been observed in pregnant animal models such as mice (Zenclussen et al., 
2005). Without the increase in Treg cells during early pregnancy accelerated rates of 
implantation failure have been reported (Shima et al., 2010). The leading theory of 
what causes the Treg cell numbers to increase is exposure to paternal seminal fluid. 
This was confirmed by the increase of Treg cells observed when female mice were 
mated with intact males (Robertson et al., 2009). However, this increase is not 
observed when females are mated with seminal vesicle excised males (Robertson et 
al., 2009). This suggests seminal plasma and possibly some spermatic factors are 
essential to the activation of Treg cells (Robertson et al., 2009). The increase in Treg 















1.7.3 The change of cytokine expression in the oviduct with advancing age 
Cytokines are a broad term for cell signalling peptides that are produced from the 
oviduct epithelial cells. These peptides will communicate with other cells to directly 
affect embryo growth. The expression of cytokines changes with increasing age, 
which could affect how the oviduct communicates to the embryo. A finding of 
increased pro-inflammatory cytokines, IL-4 and IFNG, was identified in elderly 
females compared to younger females (Pietschmann et al., 2003). An increase in IL-
3, IL-4, IL-5, and IFNG were seen in in vitro culture of CD4+ T cells collected from 
aged mice (Hobbs et al., 1993). This finding was also reported from serum levels 
where Il-6, IL-8, and TNF were increased in aged mice (Lliberos et al., 2021). Next-
generation sequencing revealed an upregulation of IL1-B, IL-1A, IL-17C, IL-8, and 
TNF in aged bovine epithelial oviduct cells (Tanaka et al., 2014). Most of these 
studies investigating the change in cytokine profile with advancing age have been 
undertaken using serum levels or cultured oviductal epithelial cells. There are 
currently no known studies that investigate the specific cytokine profile change in 
aging pregnant oviducts. Cytokines, such as the previously mentioned TNF, have 
been reported to be a selection mechanism for the survival of high-quality embryos 
(Robertson et al., 2018). This has been reported to be acting through the 
endometrial stroma and immune system to actively prevent embryos from implanting 
in adverse circumstances (Robertson, 2010; Teklenburg et al., 2010). This system is 
also theorised to spare maternal investment in pregnancy that will not result in high-
quality offspring (Robertson et al., 2018). Therefore, it is questioned what happens to 
embryo development if these cytokine profiles change with age.  
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1.7.4  Relationship of age in expression of Treg cells and their constituents  
The number and function of Treg cells changes with advancing age; however, no 
definite conclusions have been reached on what these changes are. The number of 
Treg cells in humans is reported to increase with advancing age (Gregg et al., 2005). 
Interestingly the function of human Treg cells was investigated and found to have the 
same inhibitory function independent of age (Gregg et al., 2005). This finding was 
reported a second time, concluding that the functional markers of Treg cells are 
expressed the same across young and elderly humans (Lages et al., 2008).  
Changes within the Treg cell population have also been reported in several strains of 
mice. Treg cells have been shown to decrease in the thymus but increase in the 
blood, spleen, and lymph nodes of 20-month-old Balb/c mice (Zhao et al., 2007). 
This finding was also reported in 20-month-old C57BL/6 mice and 18-20 month-old 
Balb/c mice (Lages et al., 2008; Sharma et al., 2006). The frequency of Treg cells 
has also been reported to increase in the lacrimal glands and cervical lymph nodes 
of aged mice (Paiva et al., 2019). The dysregulation of Treg cells in mice is well-
reported; however, Treg cell function has also been reported to be reduced in aged 
animals. The expression of inhibitory cytokines from aged Treg cells has been 
reported to decrease, resulting in a reduced ability to inhibit T helper cells (Zhao et 
al., 2007a). Treg cells from older mice have been reported to exhibit a lower T-cell 
inhibitory function and are less able to adapt to novel T-cell responses (Morales-
Nebreda et al., 2020). The dysregulation of Treg cell populations with increasing age 
is well established in both mice and humans. However, many of these results are 
undertaken in studies investigating infectious diseases and not how these changes 
occur within early pregnancy.  
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1.8 Project significance  
1.8.1 Experimental rationale  
The conclusions of this study will contribute to widening the knowledge of the 
aetiology of the age-related decline in female fertility.  The majority of the previous 
literature has focussed on ovarian aging, reporting the observed decline in oocyte 
number and quality. This experiment will focus on the decline in blastocyst recovery 
in young and aged mice. This will enable us to develop the background for a novel 
idea that the oviducts are a contributing factor to the age-related decline in female 
fertility. Additionally, this experiment will explore ovulation rates and time taken to 
mate to understand at which stage of pregnancy embryo loss is prominent.  
 
Over 20 years ago, a negative factor within the oviduct epithelial cells was 
discovered to decrease blastocyst development (Brinsko et al., 1994). However, no 
further research has been undertaken to discover what this negative factor is. This 
study will establish the expression of cytokines within the oviducts in young and aged 
individuals. This will increase the understanding of whether changes within the 
inflammatory response to pregnancy are dysregulated in older age.  
 
In addition to this, we will establish any changes in the T cell populations between 
young and aged mice. Understanding the age-dependent effects on T cells will allow 




An increased understanding of whether the oviduct contributes to the age-related 
decline in fertility will be beneficial to furthering our knowledge on the determinants of 
this observed decline. This knowledge may also aid the development of less invasive 
therapies to treat infertility.  
1.8.2  Objectives and hypothesis  
A link between the ageing oviduct and inferior development of embryos has been 
proposed but is not well characterised due to the lack of knowledge of the 
relationship between increasing age and the oviduct.  
 
This study aims to assess the rate of preimplantation embryo loss and possible 
inflammatory-related contributors to this loss. The aims of this research were: 
1. To investigate the percentage of blastocysts versus pre-blastocysts produced 
in young and old C57BL/6 female mice.  
2. To assess the change in growth-promoting and inhibiting factors within the 
oviduct of early pregnant mice.  
3. To characterise the populations of T cells, present within early pregnant 
young and aged mice blood samples, specifically, T regulatory cells.  
 
Therefore, this study hypothesised that the age-related increase of inflammatory 
factors in the oviducts would have a negative effect on embryo development.   
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2 Methods  
2.1 The animal model  
This study used 2.5 to 6-month-old young and 10 to 13-month-old aged adult NSE-
AMH wildtype C57BL/6 female mice. These ages were chosen as the 2.5 to 6-
month-old mice represent a peak in fertility (Guo & Pankhurst, 2020). In contrast, 10 
to 13-month-old mice were used to represent a model with a decreasing capability to 
produce offspring (Guo & Pankhurst, 2020). All animals in this study were sourced 
from the Hercus-Taieri Resource Unit of the University of Otago. Mice were housed 
in a climate-controlled environment, with controlled light/dark cycles (light phases 
12.00-0000h), and had free access to water and standard rodent food. All 
experimental animal protocols used in this study were approved by The University of 
Otago Animal Ethics Committee.  
2.2 Animal matings  
2.2.1 Culture mice  
Female mice were hyperstimulated to increase the number of embryos collected 
from the oviduct. Mice were hyperstimulated using 10IU of FSH (Genway Biotech, 
Cat #GWB-3EE59E) and 5IU of cetrorelix (Cambridge Bioscience, Cetrorelix 
Acetate, Cat #H-6682009) delivered via intraperitoneal injection for two days. The 
FSH and cetrorelix injections were delivered at 9.00 am. On the third day, the 
hyperstimulated mice were given 5IU of hCG (MERCK Animal health, Chorulon®). 
The hCG injections were given at 3.00 pm. The female mice were then placed into 
cages with males for the night. The following morning the female mice were collected 
for dissection.   
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2.2.2 RNA mice  
Young and aged female mice allocated for RNA and WBC collection were placed 
into natural mating pairs. Mice who mated overnight were identified through the 
presence of a copulatory plug. Plugs were checked at 9.00 am every morning. Upon 
visualisation of the plug, the female mouse was removed from the male’s cage and 
was placed into a separate cage until day 3.5 post-coitus, when they were then 
euthanised.  
2.3 Tissue Collection  
2.3.1 Euthanasia  
All mice were culled with a terminal dosage of Domitor (Pfizer, Cat#107332-8) at 
3mg/kg and Ketamine (PheonixPharm, Cat#DSO6/11) at 225mg/kg through 
intraperitoneal delivery. Loss of pedal reflexes was used to confirm that mice were 
adequately sedated before beginning the dissection. Exsanguination was used as 
the secondary method to confirm death.  
2.3.2 Cardiac puncture  
The base of the sternum was identified, and a midline incision through the skin and 
muscle layer was made. This incision was extended both left and right laterally. The 
sternum was clamped, and the diaphragm was envisaged and cut to release and 
expose the heart. The ribs were cut superiorly and folded back to expose the heart 
entirely. Blood was then aspirated from the right ventricle of the heart with a 1mL, 
23-gauge needle with the vessel of the needle preloaded with 0.75mg/ml EDTA 
(Sigma-Aldrich®, Ethylenediaminetetraacetic acid, CAS#60-00-4). Between 500-
800µL of blood was aspirated per mouse, the heart was then dissected out to 
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confirm death.  The needle was removed from the syringe, and the blood was 
transferred into a 15mL conical tube.  
2.3.3 White blood cell isolation  
Blood collected from the cardiac puncture was layered with 1ml of histopaque 1119 
(Sigma-Aldrich, Histopaque®-1119, Lot #RNBK3107). The blood was then 
centrifuged at 750 rcf with slow brakes for 30 minutes. The buffy layer containing the 
white blood cells was pipetted off (<500µL) and was placed into a microcentrifuge 
tube. 500µL of wash buffer made up of PBS and 2% Fetal Calf Serum (FCS) was 
added to the isolated cloudy layer, and the tube was inverted. The microfuge tube 
was spun at 8,000 rcf for 1 minute. The supernatant was pipetted off, leaving a white 
pellet. The pellet was resuspended with the wash buffer and washed again. The 
supernatant was discarded. The pellet was then resuspended in 1mL of fixative 
according to the manufacturers protocol (Thermo Fisher Scientific, eBioscience™ 
Mouse Regulatory T Cell Staining Kit #2, Cat #88-8118-40).  
2.3.4 Reproductive tract collection  
The midline incision made at the level of the sternum was extended inferiorly and 
then laterally in both directions at the region of the cervix. The gastrointestinal tract 
and fat pad were moved to expose the uterus, oviducts, and ovary. Fat pads of the 
uterus and ovary were bluntly dissected away, detaching the ovary, oviducts, and 
uterus away from the body cavity. The same procedure was carried out on the 
corresponding side. 
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2.4 Reproductive tract dissection  
2.4.1 Oviduct Isolation  
The reproductive tract was placed in pre-warmed (37°C) M2 media (Sigma-Aldrich, 
M2 medium, product #M7167). To visualise the reproductive tract, the tissues were 
placed under a Nikon SMZ18 stereomicroscope on an Okolab H401-TController 
microscope incubator stage, preheated to 37°C degrees to maintain tissue viability. 
The utero-tubal junction was cut under high magnification, isolating the oviducts from 
the uterus. The ovarian bursa was carefully pierced and then cut in a circular pattern 
ensuring the bursa was entirely disconnected from the oviducts. The ovary was 
detached from the oviducts while avoiding the ampulla. It is important not to damage 
the ampulla to avoid activating an inflammatory response. One oviduct was allocated 
to the embryo in vitro culture, while the second oviduct was allocated to the oviduct 
in situ culture.    
2.5 Embryo in vitro cultures  
2.5.1 Media and plate preparation  
The UV cabinet was turned on and sterilised for 30 minutes. A 4-well plate 
(ThermoFisher Scientific, Nunc™ 4-Well Dishes, Cat #144444) was prepared for 
cumulus cell removal of the zygotes under the UV hood. Wells, 1, 3, and 4 contained 
500µL of M2 medium, and well 2 contained a 1:1 ratio of M2 medium and 
hyaluronidase (figure 2.1a). The plate was warmed to 37˚C degrees.  
 
The number of animals dissected on the same day corresponded to how many petri 
dishes (Corning, 35mm falcon® easy-grip cell culture dish, product #353001) were 
required for the embryos to be cultured. Under the UV hood, a 40µL droplet of M16 
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was pipetted into the centre of the petri dish (figure 2.1b). In a circular formation, 6 x 
20µL droplets were pipetted around the 40µL droplet (figure 2.1b). 3mL of Ovoil 
(Vitrolife, Ovoil™) was slowly pipetted to cover the seven droplets avoiding any 
bubbles throughout the plate by running the oil down the side of the petri dish. The 
embryo culture dish was placed in the 37°C, 5% CO2, 21% O2 incubator and left for 2 
hours to balance the media.  
Figure 2.1 Embryo in vitro culture plates. (a), 4 well plate for cumulus cell removal of 
the zygotes. (b), 35mm petri dish where the embryos will be cultured for 3.5 days.  
2.5.2 Retrieval of the zygotes and embryo culturing 
After the isolation of the oviducts, the ampulla was identified by its fluid-filled 
characteristic and striated epithelium. The ampulla was sliced cleanly in one 
movement under the stereomicroscope using a 21-gauge needle and its bevel, 
releasing the COCs from the oviduct. The COCs were then mouth pipetted into M2 
medium and placed on a 37°C degrees heat pad. The oviducts were then diced with 
21-gauge needles to confirm that all COCs were retrieved. The COCs collected from 
the oviducts were then moved via mouth pipetting into hyaluronidase to remove the 
cumulus cells. Zygotes were pipetted up and down to aid the process of cumulus cell 
removal and were moved back into M2 within five minutes of being in hyaluronidase. 
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In the M2, zygotes were washed briefly and then moved to new M2. Once all zygotes 
were in the last M2 wash, the zygotes were staged. Only zygotes that were fertilised 
were transferred into the embryo culture. Fertilisation was identified through the 
presence of an extruded polar body or two pronuclei (figure 2.2). The fertilized 
embryos were washed in the 40µL M16 droplet in the petri dish and cultured in an 
M16 20µL droplet for 3.5 days. On day 2.5 of the culture, the embryos were moved 
to a new 20µL droplet to provide new growth supplements to continue promoting 










Figure 2.2 Example of a fertilised zygote (Nagy et al., 2003). The white arrow is 
indicating the presence of two pronuclei. The black arrow is indicating the presence 
of a polar body. 
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2.6 Oviduct in situ cultures  
2.6.1 Plate preparation  
A 24-well plate with transwell inserts (0.4μm pore size, 12mm diameter, MillicellⓇ, 
Merck KGaA, CAT#PIHP01250) was used to culture the oviducts. M16 media with 
0.01% antibiotic-antimycotic (Anti-Anti, 100x, Gibco®, CAT# 1520096) was also 
used to culture the embryos inside the oviduct. The plate contained 500µL of media 
in the well and a 2µL droplet of M16 on the insert. The plate was placed in a 37°C 
degrees, 5% CO2, and 21% O2 incubator for 2 hours before starting the culture for 
equilibration.  
2.6.2 Oviduct preparation and media changes 
Prior to culturing, the presence of COCs in the ampulla of the oviduct was confirmed 
through high exposure under the stereomicroscope. Oviduct health was also 
estimated through the presence of contractions and the size of the fluid-filled 
ampulla. The oviduct was placed in the 2µL droplet, and the plate was returned to 
the incubator. The oviduct was cultured for 3.5 days in total. Media changes 
occurred on days 1.5 and 2.5 of the in-situ oviduct culture. 250µL of the media from 
the well of the 24-well plate was aspirated and discarded. 300µL of new M16 and 
antibiotic-antimycotic media was pipetted into the well. The 50% media change was 
used to provide the oviducts and embryos with new growth supplements without 
disturbing the growth factors already established. Estimations of oviduct health 
through visualisation of the ampulla contractions and ampulla size were made during 
the media changes.  
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2.6.3 Ending of in situ cultures  
At the end of 3.5 days, the oviducts were placed into organ culture dishes (Fisher 
Scientific, Falcon™ Organ Culture Dish, product #10049210) with M2 medium. The 
oviduct was then placed under the stereomicroscope with low light. Oviduct health 
was observed through the level of contraction and ampulla fluid. The ampulla was 
sliced through once with a 21-gauge needle, releasing the cultured embryos. After 
identifying the embryos present, the oviduct was diced to release any extra embryos. 
The embryos were then imaged and staged.  
2.7 Embryo staging  
Embryos in the in vitro culture were staged every day at 3.00 pm. On day 3.5, both 
the embryo in vitro culture and oviduct in situ culture embryos were staged. All 
benches and microscopes that the dish could contact were sterilised with 70% 
ethanol. The stages observed throughout the 3.5 days of culture were determined by 
the number and formation of cells present in the embryo. These stages included one 
cell, two-cell, four-cell, 8-16 cell, morula, compact morula, early blastocyst, and 
expanded blastocyst embryos (figure 2.3). The difference observed between a 
morula, and a compacted morula was determined by the tightness of the cells (figure 
2.3e-g). The difference between an early blastocyst, an expanded blastocyst, and a 
hatching blastocyst was determined by the percentage of blastocoel, where over 
50% was considered an expanded blastocyst (figure 2.3h-j). A percentage of 
embryos in the cultures would not survive to the blastocyst stage and would begin to 
degrade during the culture period. Typical degrading embryos are displayed in figure 
2.4. Most degrading embryos were characterised by a loose zona pellucida, 
fragmentation, and shrinking inner cell mass (figure 2.4).  
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Figure 2.3 Stages of embryonic development that occur in the first 3.5 days of pregnancy. (a), embryonic day 0.5 one cell embryo 
with an extruded polar body. (b), embryonic day 1.5 two cell embryo. (c), embryonic day 2.0 four cell embryo. (d), embryonic day 
2.5 eight cell embryo. (e), embryonic day 3.0 sixteen cell embryo. (f) embryonic day 3.0 compacting morula. (g), embryonic day 3.0 
fully compacted morula. (h), embryonic day 3.5 early blastocyst. (i) embryonic day 3.5 fully expanded blastocyst. (j) embryonic day 


















Figure 2.4 Examples of degrading embryos. (a), early embryonic stage degrading 
embryo with multiple fragments. (b), late stage degrading embryo with high 
fragmentation. (c), degrading one cell embryo with two polar bodies. (d), early 




2.8 Natural mating mice model 
2.8.1 Oviduct RNA preservation 
Before the oviducts were taken out of the body cavity of the mice that were 
dedicated to RNA and WBC collection, the RNA was preserved. 30µL of RNAlater 
(Invtirogen™, RNAlater™, Cat #AM7021) was used to wash over each oviduct to 
stop the RNA from degrading. The oviducts were then removed from the body cavity, 
dissected away from the ovary and uterus, and placed in 30µL of RNAlater in a 
microfuge tube. The oviducts were incubated in RNAlater for 2 hours at 4˚C degrees 
At the end of the incubation period, the RNAlater supernatant was removed, and the  
oviducts were frozen at -80°C degrees until ready for RNA isolation. 
2.8.2 Uterine flushes  
The uteri from day 3.5 pregnant mice were then used to collect and stage the 
embryos. A 1mL 23-gauge needle and syringe were loaded with 1mL of M2 media. 
The needle was inserted into the uterotubal junction of the uterus and slowly 
delivered, flushing out any embryos present in the uterus into an organ culture dish. 
The dishes were placed under a stereomicroscope with low light to identify and stage 
the embryos. The embryonic staging criteria are presented in figures 2.3 and 2.4.  
2.9 RNA extraction  
2.9.1 RNA isolation 
Oviduct RNA was extracted with TRI reagent (Sigma-Aldrich, TRI Reagent®, 
Product #T9424) according to the manufacturers protocol. 
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2.10 CDNA preparation  
2.10.1 Degradation of DNA 
The concentration of RNA was determined using a nanodrop 2000 (Thermo 
Scientific™, Nanodrop™ 2000/2000c Spectrophotometer). After determining the 
concentration of the RNA and the amount of RNA required to be added for cDNA 
synthesis, a reaction mix was made up (table 2.1). Each sample was then incubated 
at 37°C degrees for 30 minutes. The DNAse reaction was inactivated by heating the 
samples to 75°C degrees for 5 minutes. The tubes were left to cool. 
Table 2.1 DNAse treatment master mix  
Reagents µL/test 
10X Turbo Buffer 1µL 
Turbo DNAse 1µL 
DepC Ultrapure dH2O 8µL-XµL 
RNA XµL 
Total 10µL 
2.10.2 CDNA synthesis 
A second master mix was made for cDNA synthesis of RNA according to table 2.2. 
Tubes were then incubated at 65°C for 5 minutes, chilled on ice for 1 minute and 
pulse spun.  
 
The third master mix was made according to table 2.3. 8µL of the master mix was 
added to each sample and then gently mixed and incubated at 25°C degrees for 5 
minutes. Samples were further incubated at 42°C degrees for 60 minutes. Finally, 
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the reaction was terminated at 70°C degrees for 5 minutes. Samples were kept at -
1°C degrees overnight. 
Table 2.2 cDNA synthesis master mix.  
Reagents µL/test 
DepC Ultrapure dH2O 6µL 
Random Hexamer Primer  1µL  
RNA Template  5µL 
Total 12µL 
 
Table 2.3 cDNA synthesis master mix 2. 
Reagents µL/test  
5X reaction buffer 4µL  
RiboLock RNase Inhibitor 1µL  
10mM dNTP RNase Inhibitor   2µL  
RevertAid M-MuLV RT  1µL 
Total 8µL 
 
2.11 Quantitative polymerase chain reaction  
2.11.1 Growth factor primer design 
The majority of the primers used in this study were designed in 2015 by a Bachelor 
of Biomedical Sciences Honours student, Rachel Sanders (Sanders, 2015). 
However, three primers were designed for this study, IGF1, FGF1, and TNF. Primers 
for the molecules of interest were designed using primer-BLAST software on the 
National Centre for Biotechnology Information (NCBI). The mRNA sequences of 
interest were obtained through searching the gene database using mus musculus as 
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the species of interest for the three genes. The mRNA sequences were pasted 
directly into the PCR template box of primer-BLAST. The primer length was limited 
between 100 and 200 base pairs, the rest of the functions remained on the default 
setting. The criteria for selecting a primer were to maintain the self-complementarity 
below 3 and the GC content was between 40-60%, the closer to 50% being the most 
ideal. A GC clamp was also included in all three primers designed. Each primer was 
also selected on the basis that the melting temperature of the forward primer was as 
close as possible to the reverse primer. The selected sequences were ordered from 
Integrated DNA Technologies.  
2.11.2  Preparation of growth factor primers  
Under a UV hood, a primer master mix was made up for each primer tested 
according to table 2.4. The growth-promoting and inhibiting primer sequences used 
in this study are presented in tables 2.5 and 2.6. Utilising a Roche white 96 well PCR 
plate, 15µL of the master mix was added to the appropriate wells. The cDNA was 
diluted 1:5 by adding 100µL of depC water to the reaction tube. Lastly, 5µL of cDNA 
was added to the appropriate wells of the 96 well plate. Two types of controls were 
run on each qPCR plate, a no template, NT, control, and a no reverse transcriptase, 
NRT, control. An NT control contained 15µL of primer master mix and 5µL of depC 
water. An NRT control contained 15µL of primer master mix and 5µL of an RNA 
sample that was DNAse treated but was not synthesised into cDNA. The plate was 
sealed with Roche Light cycler plate foils and weighed. The plate was then 




Table 2.4 qPCR primer master mix. 
Reagents  µL/reaction 
DepC Ultrapure dH2O 4.6µL  
SYBR Green  10µL 
Forward Primer (100µM) 0.2µL  
Reverse Primer (100µM) 0.2µL 
Total  15µL  
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Table 2.5 Embryo growth-promoting factors sequence information for qPCR of oviduct mRNA transcripts in wild type dams 3.5 days 
post-coitus.  
Transcript Access Number Primer Sequence Wild-type  





1.1 x10−3 ± 1.4 x10−4 
 
CSF2 NM_009969.4 5’GCTCACTGGCCCCATGTATAG3’ 
5’ACTGGGCTCACTGCAAAAGA3 
7.2 x10−7 ± 2.9 x10−7 
 
IL6 NM_031168.2 5’CCGGAGAGGAGACTTCACAG3’ 
5’CAGAATTGCCATTGCACAAC3’ 
 
7.5 x10−4 ± 1.6 x10−4 
 
PDGFA NM_008808.3 5’TCTCCGCTGTCGCCTAGATT3’ 
5’TCATCTCGCGCCAATCACAG3’ 
 
5.9 x10−2 ± 5.4 x10−3 
 
KITLG NM_013598.3 5’AGAAGACACAAACTTGGATTATCAC3’ 
5’CATCCCGGCGACATAGTTGA3’ 
 
1.2 x10−2 ± 1.3 x10−3 
 
FAAH NM_010173.4  5’GACCCCTTCGTGTGGGATAC3’ 
5’GGGCAGCTTCAGCACTAAGA3’ 
 
1.7 x10−3 ± 1.9 x10−4 
 
IGF1 NM_010512.5 5’TTCGCCTCATTATCCCTGCCC3’ 
5’AGCCTGTGGGCTTGTTGAAGT3’ 
 
FGF1 NM_010197.3 5’ACAGGAGCGACCAGCACATT3’ 
5’ATTTGGTGTCTGCGAGCCGT3’ 
 






Table 2.6 Embryo growth-inhibiting factors sequence information for qPCR of oviduct mRNA transcripts in wild type dams 3.5 days 
post-coitus. 
Transcript Access Number Primer Sequence Wild-type  





1.2 x10−3 ± 1.0 x10−4 
 
TNFSF10 NM_009425.2 5’TCCAGCCACAGACACTTTCG3’ 
5’TTGGCTTTACACCCCTGGAC3’ 
 
1.9 x10−2 ± 2.3 x10−3 
 
IFNG  NM_008337.4 5’ACTGTGATTGCGGGGTTGTA3’ 
5’ACATTCGAGTGCTGTCTGGC3’ 
 
1.0 x10−5 ± 2.2 x10−6 
 




2.11.3 Light cycler 480 
The qPCR protocol was run on the Light Cycler 480 machine (Roche, LightCycler® 
480 Instrument II). The conditions were set to preheat for 50°C degrees for 2 
minutes and 95°C degrees for 15 minutes for one cycle. The preincubation cycle was 
followed by 50 cycles of amplification at 95°C degrees for 20 seconds, 60°C degrees 
for 20 seconds, and 72°C degrees for 30 seconds at a single acquisition. The 
melting curve consisted of a single cycle of 95°C degrees for 5 seconds, 65°C 
degrees for 1 minute, and 97°C degrees continuous acquisition. Finally, the cooling 
cycle chilled the reaction to 40°C degrees for 30 seconds.  
After running the protocol, cDNA samples with a CT value of 45 and above were 
excluded from the sample (table 2.7).  
Table 2.7 Exclusion categories for RT-qPCR cDNA samples. 
Reason for exclusion Number of cDNA + primer samples 
excluded  
 Young mice Aged mice 
CT value equal to or above 45  7 8 
2.12 Spectral cytometry 
2.12.1 Giemsa stain  
White blood cell smears were prepared from the white blood cell isolation protocol. A 
Giemsa stain was prepared to confirm the presence of white blood cells within the 
pellet. Giemsa stock solution was made by adding 7.36g of Giemsa powder to 
500mL of glycerol. The mixture was left for 30 minutes at 50°C degrees with periodic 
mixing. The mixture was left to cool to room temperature when 500mL of methanol 
was added. The stock solution was then filtered. The Giemsa stock was then diluted 
to 1 in 50.  
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The white blood cell smear was fixed in methanol for 5 minutes. The fixed slide was 
then left in the Giemsa solution for 40 minutes. After 40 minutes, the slide was rinsed 
rapidly with distilled water, blotted dry, and mounted. The slide was envisaged and 
imaged using an Axioplan microscope (ZEISS) with the AxioCam HR colour digital 
CCD camera (ZEISS), which uses the AxioVision40 software. 
2.12.2 Autofluorescence adjustment  
As samples were incubated at 4˚C degrees for up to 5 months, autofluorescence 
adjustment was required. The day before spectral cytometry occurred, the fixative 
was removed from the pellets. The pellets were washed twice with 1mL of PBS-
glycine solution (0.76g/100mL). Centrifugation separated the washes at 8,000 rcf for 
1 minute. The white blood cell samples were then photo-bleached under the blue 
light of a Nikon SMZ18 stereomicroscope for two hours. Glycine treatment of cells 
allowed the glycine molecules to bind to any available sticky ends present in the 
paraformaldehyde in the fixative. While photo-bleaching the cells decreased the non-
specific staining of cells. 
2.12.3 Permeabilization of the white blood cells  
The young and aged white blood cell pellets were split into two different staining 
combinations, CD3+, and CD4+, CD4+, and Foxp3+. All samples were centrifuged at 
8,000 rcf for one minute after the UV treatments were completed. The supernatant 
was discarded, and the pellet was resuspended in a 1X solution of permeabilization 
buffer (Thermo Fisher Scientific, eBioscience™ Mouse Regulatory T Cell Staining Kit 
#2, Cat #88-8118-40). The samples were then spun for a further 5 minutes at 400g. 
A second spin followed this spin at 8,000 rcf for one minute. The supernatant was 
discarded, and the pellet was resuspended in 100µl of 1X permeabilization buffer. 
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2.12.4 Blocking the white blood cells for staining  
All samples that were to be stained with Foxp3+ were blocked with 20µg/mL of 
CD16/32 monoclonal blocker antibody. This was completed to inhibit any binding of 
fluorophores to the Fc receptors found on white blood cells. The samples were left to 
incubate at room temperature for 15 minutes. 
2.12.5 Extracellular and intracellular staining of white blood cells 
Each white blood cell sample was stained individually. The CD4+ antibody was 
added at a concentration of 2.5µg/mL. The CD3+ antibody was added at a 
concentration of 2µg/mL. The Foxp3+ antibody was added at a 10µg/mL 
concentration. Each sample was carefully titrated and placed in the 4˚C degrees 
fridge overnight while also being protected from light.  
 
The following day the stain was washed off with 500µL of 1X permeabilization buffer. 
The samples were then centrifuged at 400g for 5 minutes, followed by a faster spin 
at 8000 rcf for one minute. The wash was carried out a second time. The pellets 
were then resuspended in 500µL of flow cytometry staining buffer (Thermo Fisher 
Scientific, eBioscience™ Mouse Regulatory T Cell Staining Kit #2, Cat #88-8118-
40). The samples were then transferred into flow cytometry tubes (pluriSelect, Flow 
Cytometry Tube 5mL).  
2.12.6 Spectral Cytometry   
The spectral cytometry was run on a Cytek Aurora (Cytek® Aurora). Three 
antibodies were tested, CD3+ as a marker for T cells, which used the fluorophore 
APC. CD4+ as a marker for T helper cells was measured through a FITC 
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fluorophore. Lastly, Foxp3+ was a marker for T regulatory cells, which was 
measured through the APC fluorophore.  
2.13 Statistical analyses  
Student’s t-tests were applied to compare the number of ovulations between young 
and aged mice, represented through the number of corpora lutea present in the 
ovary. Student’s t-tests were also used to compare the time taken for young and 
aged mice to mate. A fisher’s exact test was used to compare the percentage of 
survival of the embryos to the blastocyst stage in young and aged mice.  
 
 A Delta CT analysis and Student’s t-test were applied to compare the amount of 
growth-promoting or inhibiting factors present in the oviducts between young and 
aged mice. These analyses were completed using Prism 9 GraphPad Software with 
p<0.05, indicating significance.  
 
The spectral cytometry raw results were stored and analysed using Flow Jo version 
10.0 software. Once the populations had been isolated, the statistics were exported. 
Student’s t-tests were carried out to determine if any significant changes in white 











3 Results  
3.1 Oviduct and embryo co-culture technique development  
This study involved multiple novel techniques that required a period of method 
design and optimisation of the protocols designed. The development of an oviduct 
embryo co-culture protocol was undertaken during this project. Embryos were 
cultured inside an oviduct for 3.5 days to grow zygotes to the blastocyst stage of 
embryonic development. Previously embryos and oviduct epithelial cells have been 
cultured in an in vitro model. However, the in-situ culture of murine embryos within 
murine oviducts has not been used to consider the ageing process of the oviduct and 
its effect on embryo development. Therefore, the protocols to keep the oviduct alive 
for 3.5 days and grow blastocysts within the oviduct needed to be developed and 
optimised before the data collection began.  
3.1.1 Oviduct culture survivability  
This section describes the developmental stages undertaken to successfully culture 
young and aged murine oocyte-derived embryos inside young and aged murine 
oviducts. Before attempting to grow embryos inside an oviduct, a preliminary culture 
of an oviduct with no embryos present in the ampulla was completed. This was to 
establish that the oviduct would stay alive for 3.5 days as this had not been 
completed in the lab before. The oviducts were dissected out and placed into culture 
with DMEMF/12 media for 3.5 days. On day 3.5 of the culture, the oviducts were 
stained with propidium iodide. Propidium iodide staining was used as it is a 
fluorescent red stain that will incorporate itself into the nucleic acids of dead cells 
with a damaged membrane. Oviducts were stained after 3.5 days of culture and 
were observed to have a small percentage of cell death (figure 3.1). Dead cells 
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appeared in clusters on the outside of the oviduct structure and did not appear to 
spread throughout the oviduct. The small percentage of death confirmed that the 
oviducts were still alive after 3.5 days of culture in DMEMF/12 with no supplemented 






































Figure 3.1 Propidium iodide staining of day 3.5 cultured oviducts. Oviducts were cultured in DMEM/F12 media for 3.5 days in 95% 
O2 and 37°C degrees. White arrows indicate where dying oviduct cells have taken up the propidium iodide stain. Images were 
taken at 30x. 
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3.1.2 Oviduct embryo co-cultures  
The following optimisation technique was to culture an oviduct with zygotes present 
in the ampulla. This was to confirm that it was possible to grow zygotes to the 
blastocyst stage in 3.5 days within the oviduct. The first oviduct and embryo co-
cultures were cultured in DMEMF/12 media. The decision to culture in DMEMF/12 
was made due to the media not containing any growth sera to support the growth of 
the oviduct or embryos. This meant we could establish how much support the culture 
needed to survive without promoting growth. As this could conceal any difference 
between young and aged embryo growth within the oviducts.  
 
The first cultures using DMEMF/12 failed to produce any living embryos. On day 0.5, 
the ampulla of the oviduct was fluid-filled, and contractions of the ampulla region 
were observed during the dissection (figure 3.2a). However, on days 2.5 and 3.5, the 
ampulla had collapsed and was no longer fluid-filled or contracting (figure 3.2b & c). 
The embryos from the oviduct were then dissected out from the ampulla on day 3.5. 
The embryos from the oviduct were surrounded by cumulus cells, which in normal 
embryonic development are last seen on day 1.5 of pregnancy (figure 3.2d). The 
embryos were treated with hyaluronidase to isolate the embryos from the cumulus 
cells. All embryos that were collected from the oviduct on day 3.5 were degrading. 
The degrading phenotype was identified through a loose zona pellucida, 





































Figure 3.2 Unsuccessful oviduct and embryo co-culture. (a), day 0.5 pregnant 
oviduct with a fluid-filled ampulla. (b), day 2.5 pregnant oviduct with a collapsing 
ampulla. (c), day 3.5 pregnant oviduct with a collapsing ampulla. (d), embryos and 
cumulus cells released from the oviduct after slicing the ampulla open. (e), cumulus 
cells were removed with hyaluronidase treatment revealing 5 degrading embryos. 
Oviducts were cultured in DMEM/F12 medium for 3.5 days. Black arrows indicate the 





After several attempts of culturing within DMEMF/12 and dissecting out degrading 
embryos on day 3.5 of the oviduct embryo co-culture, the culture medium was 
changed to M16 media. M16 is a media that contains pyruvate and lactate and is a 
specifically designed medium to support preimplantation embryonic growth.  Thus, 
the change to M16 media from DMEMF/12 was made to promote embryo growth 
further as DMEMF/12 did not provide enough support to keep embryos alive. After 
the change to M16 media, the oviducts had a significant increase in health. This was 
observed through the ampulla contracting for the entire 3.5 days suggesting the 
oviduct was alive. The ampullas fluid filled feature was also maintained for the 3.5 
days of culture (figure 3.3a-c). The embryos were dissected out of the ampulla 
region on day 3.5 of the culture. The embryos collected were of various stages, 
including a morula embryo and two blastocyst embryos (figure 3.3d & e).  The 
retrieval of blastocysts confirmed that the current protocol is keeping the oviduct 
alive and healthy for 3.5 days and allowing the oviduct to maintain the support of 




























Figure 3.3 Successful oviduct and embryo co-culture. (a), day 0.5 pregnant oviduct 
with a fluid-filled ampulla. (b), day 2.5 pregnant oviduct with a fluid-filled ampulla. (c), 
day 3.5 pregnant oviduct with a fluid-filled ampulla. (d, e), embryos retrieved from 
day 3.5 pregnant cultured oviducts. The red arrows indicate the fluid-filled ampulla of 
the oviduct. The white arrows indicate blastocysts characterised through the 
blastocoel cavity. The black arrow indicates a compact morula.  
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The last step in the culture protocol development was to cross pipette young and 
aged oocyte-derived embryos into young and aged recipient oviducts. Four 
experimental groups were to be included, young oviducts with young embryos, 
young oviducts with old embryos, old oviducts with old embryos, and old oviducts 
with young embryos. This was to identify how the aged oviduct affects embryo 
development compared to the young oviduct without the confounding effects of 
oocyte quality. Four of these cultures were run, and 50% were successful. Of the two 
unsuccessful cultures, one produced degrading embryos, and the second had 
squeezed the embryos out of the ampulla from the oviduct contractions. The two 
successful cultures grew 20% of the zygotes transferred into the oviduct to the 
blastocyst stage. However, due to the squeezing out of the embryos, the cross 
pipetting of embryos was halted. The final culture protocol described in chapter 2 
was then designed.    
3.1.3 Oviduct in situ culture and embryo in vitro culture  
The final culture protocol developed included an in-situ oviduct and an embryo in 
vitro culture. The oviduct in situ culture was included where female mice were mated 
the night before euthanasia. The oviducts were dissected out on day 0.5 of 
pregnancy and placed directly into culture with the recently fertilised embryos 
present in the ampulla (figure 3.4a). On day 3.5 of the oviduct in situ culture, the 
embryos were dissected out of the ampulla and staged (figure 3.4b). The only 
change to the oviduct in situ protocol was that the oxygen concentration was 
decreased to 5% O2 instead of 95% O2 used initially. This was to support the new 
embryo in vitro culture that was to be included in the protocol as embryos in vitro 
require a low oxygen environment to grow. The embryo in vitro culture protocol 
required the use of the embryos from the second oviduct of the mouse. On day 0.5 
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of pregnancy, the fertilised zygotes were dissected from the ampulla and placed in 
culture (figure 3.4c). On day 3.5 of the culture the embryos were staged at the same 
time the oviduct in situ culture embryos were staged (figure 3.4d). The oviduct in situ 
culture was applied to model the effect of aging of the oviduct on embryo 
development. These results would have been compared to the embryo in vitro 
culture protocol as this culture models favourable growth conditions and removes the 
effect of the oviducts. Approximately 66% of both the in situ and in vitro cultures 
produced blastocysts. 
 
However, the percentage of embryos surviving to the blastocyst stage in both the in 
situ and an in vitro culture protocol remained below 10%. The culture required two 
further changes to optimise the protocol. Since the growth of embryos was slow, it 
was decided to stop hyper-stimulating the animals to increase the quality and speed 
of growth. The gas conditions were also changed back to a high oxygen environment 
to support the oviduct survivability. As it appeared when the oviduct was placed in a 
low oxygen environment, the fluid-filled ampulla and contractions within the ampulla 
region were less consistent and not maintained for the entire culture period. It was 
shown that the culture protocol developed in this study was successful as embryos 
were showing development to the blastocyst stage in 3.5 days. However, to reflect 
natural development the number of embryos surviving to the blastocyst stage 























Figure 3.4 The novel culture protocol developed. (a), Oviduct in situ culture collected on day 0.5 of pregnancy, error bar denotes 
1000µm. (b), Embryos were dissected out from ampulla on day 3.5 of the in situ culture. (c), Embryo in vitro culture using one cell 
embryos collected from a day 0.5 pregnant oviduct, error bar denotes 100µm. (d), Embryo in vitro culture on day 3.5 of the culture, 
error bar denotes 1000µm. White arrows indicate blastocysts.  
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3.1.4 COVID-19 
This novel culture protocol took five and a half months to develop and proved to be 
successful. Success was observed and defined through the ability to keep the 
oviduct alive for 3.5 days and on the last day of culture, dissecting out blastocysts 
and a range of differently staged embryos. The culture protocol developed in this 
study confirmed for the first time that it is possible to study the effect of the aging 
oviduct on embryo development in an in-situ culture model.  While this protocol was 
proven to be possible unfortunately, it could not be carried out due to COVID19 












3.2 Investigating the blastocyst rate in vivo in young and aged 
animals  
3.2.1 Average number of corpora lutea ovulated  
To determine if there was a difference in the number of eggs ovulated with 
advancing maternal age, an external count of corpora lutea within the ovary on day 
3.5 pregnant mice was completed. This was important to determine to observe 
whether or not the aged mice are experiencing ovarian reserve exhaustion and if this 
is a contributing factor to the age-related decline in fertility in our model. Figure 3.5 
exhibits the external count of corpora lutea within the ovary. Young mice, on 
average, ovulated 4.25 corpora lutea in the oestrous cycle they became pregnant, 
and aged mice ovulated on average 6.00 corpora lutea (figure 3.5). A Student’s t-test 
revealed no significant difference in the number of corpora lutea between young and 
aged mice (P = 0.206) (figure 3.5). The lack of difference in the number of corpora 
lutea ovulated suggested that mice are ovulating on average the same number of 





































Figure 3.5 Average number of corpora lutea ovulated on the cycle the young, and 
aged mice became pregnant. The data presented here is the total number of corpora 
lutea ovulated relative to the number of mice included in the sample. The median is 
presented with the solid black line, and the error bars denote the interquartile range. 
Circles represent individual values. The number of young animals included was 8 (n 
= 8), and the number of old animals included was 10 (n = 10). A Student’s t-test was 















3.2.2 Time taken to mate  
In order to investigate if there was a difference in oestrous cycling between young 
and aged mice, the time taken to mate and become pregnant was determined. 
Figure 3.6 displays the average number of days a mouse took to mate. On average 
young mice took 2.33 days to mate, and aged mice took 3.65 days (figure 3.6). 
There was no significant association between the days taken to mate and the age of 
the mice (P = 0.083) (figure 3.6). The lack of difference in the days taken to mate 
illustrated that young and aged mice were cycling at the same pace. It was also 
concluded that mice are likely to become pregnant on the same cycle number 
independent of age. 
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Figure 3.6 Average number of days taken for young and aged mice to mate. The 
data is presented as an average of the total number of days taken to mate relative to 
the number of mice included in the sample. The median is presented with the solid 
black line, and the error bars denote the interquartile range. Circles represent 
individual values. The number of young animals included in this sample was 18 (n = 
18), and the number of old animals included was 20 (n = 20). A Student’s t-test was 
used to calculate the difference between the means.  
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3.2.3 Average blastocysts produced per corpus luteum  
The number of blastocysts produced per corpus luteum were analysed to investigate 
whether the number of oocytes being released and fertilised changed with advancing 
age. Figure 3.7 displays, on average, the number of blastocysts produced per corpus 
luteum. The number of oocytes ovulated can be presumed from the number of 
corpora lutea counted within the ovaries. However, this is an external count 
completed on the ovary and therefore may introduce some variation. Young mice, on 
average, produced 0.72 blastocysts per corpus luteum, and old mice produced 
0.3529 blastocysts per corpus luteum (figure 3.7). There is a value in the young 
sample that reports 1.5 blastocysts were produced from a corpus luteum (figure 3.7). 
This could result from twins being produced from a single corpus luteum. However, 
twins are very rare in murine species. It is more likely that a corpus luteum was 
missed within an ovary during the count resulting in this anomaly. There was no 
significant difference in the average blastocyst produced per corpus luteum between 
the young and aged mice (P = 0.0927) (figure 3.7). The lack of difference confirmed 
that the same number of eggs on average are being released from the corpora lutea 
and fertilised between young and aged mice. Therefore, if the number of embryos 
surviving to the blastocyst stage varies between the young and aged animals, it 
cannot be due to a different number of oocytes being released from the corpora lutea 





Figure 3.7 Number of blastocysts produced per corpus luteum in young and aged 
animals. The data is presented as an average of the number of blastocysts produced 
relative to the number corpora lutea produced per young or aged mouse. Data are 
mean ± SEM. The number of young mice included was 6 (n = 6), and the number of 
old mice included was 10 (n = 10). A Student’s t-test was used to calculate the 












3.2.4 Survival of embryos to the blastocyst stage  
Uterine flushes at day 3.5 of pregnancy were undertaken to investigate whether the 
number of blastocysts produced differs between young and aged mice. Figure 3.8 
exhibits the number of embryos that survived to the blastocyst stage in young and 
aged mice. Within the young mice, 84% of embryos survived to the blastocyst stage 
(figure 3.8). Whereas in the aged mice, only 57% of embryos survived to the 
blastocyst stage (figure 3.8). The percentage of embryos surviving to the blastocyst 
stage in young mice was significantly higher than the percentage of blastocyst 
survival in aged mice (P < 0.0001) (Fishers exact test) (figure 3.8). This suggested 
that young mice could support the growth of embryos to the blastocyst stage to a 






Figure 3.8 The number of embryos surviving to the blastocyst stage at 3.5 days of 
pregnancy. Data presented here was produced by taking the total number of 
blastocysts and dividing this by the total number of embryos produced by the young 
or aged animals. Significance was calculated using a Fishers Exact Test. 
Significance is denoted by the asterix symbol. The number of young embryos 
included in the sample was 55 (n = 55) while the number of old embryos included in 















3.3 Evaluating the levels of growth promoting and growth inhibiting 
factors in young and aged mice oviducts  
3.3.1 Growth promoting factors  
Real-time qPCR was completed to investigate the change of expression of 
embryonic growth promoters present within the oviduct in young and aged mice. This 
was to confirm if there is a change in communication between the maternal and 
embryonic tissue in aged mice that may explain why significantly fewer embryos are 
surviving to the blastocyst stage. Figure 3.9 displays the relative gene expression of 
8 different growth promoters using the housekeeping gene BACT as a reference. No 
significant differences (P > 0.05) were found in any growth-promoting factor when 
comparing young and aged mice relative gene expression (figure 3.9).  
 
The dot plots presenting CSF2 and FGF1 appeared to have two distinct populations 
of individual points (figure 3.9b & h). It was theorised that these two populations 
might represent mice that produced embryos on day 3.5 of pregnancy and mice that 
did not. The mice who did not produce any embryos were excluded from the sample 
and the analysis was repeated. However, the variation remained the same, and the 
two populations were still present after excluding these animals from the sample 
















Figure 3.9 Relative gene expression of growth promoting factors in female mice who showed a copulatory plug 3.5 days prior. Data 
presented here is the log transformed relative gene expression of growth promoting factors within day 3.5 pregnant mice oviducts. 
Relative gene expression was calculated using the single delta CT value of the gene of interest divided by the single delta CT value 
of the house keeping gene. (a), epidermal growth factor relative gene expression, (nyoung = 15), (naged = 16). (b), colony 
stimulating factor 2 relative gene expression, (nyoung = 13), (naged = 18). (c), interleukin 6 relative gene expression, (nyoung = 
14), (naged = 14). (d), platelet derived growth factor subunit A relative gene expression, (nyoung = 17), (naged = 20). (e), kit ligand 
relative gene expression, (nyoung = 16), (naged = 19). (f), fatty acid amide hydrolase relative gene expression, (nyoung = 14), 
(naged = 20). (g), insulin-like growth factor 1 relative gene expression, (nyoung = 12), (naged = 19). (h), fibroblast growth factor 1 
relative gene expression, (nyoung = 14), (naged = 15). Data are mean ± SEM. A Student’s t- test was used to calculate the 
difference between the means.  
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3.3.2 Growth inhibiting factors  
The growth-inhibiting factors present within the oviduct may also explain the 
decrease in blastocyst rate in aged animals. To find if this is true, RT-qPCR was 
used to measure the relative gene expression of 4 different growth inhibitors. Figure 
3.10 displays the relative gene expression of growth-inhibiting factors in young and 
aged day 3.5 pregnant oviducts. No growth inhibitor showed a significant difference 
(P > 0.05) in relative gene expression between young and aged mice (figure 3.10). 
 
Interestingly, the data produced from the growth-inhibiting factors presented with 
high variation. The aged mice presented with more variation than the young mice, 
seen in the spread of the individual data points and larger error bars (figure 3.10). It 
was theorised that this variation might be due to dysregulation within the growth-
inhibiting factors occurring in the aged mice. Kolmogorov-Smirnov tests were carried 
out on each growth-inhibiting factor to determine if this variation was significant. No 
significant differences (P > 0.05) between the variations of young and aged animals 





Figure 3.10 Relative gene expression of growth-inhibiting factors in female mice who 
showed a copulatory plug 3.5 days prior. Data presented here is the log-transformed 
relative gene expression of growth-inhibiting factors within day 3.5 pregnant mice 
oviducts. Relative gene expression was calculated using the single delta CT value of 
the gene of interest divided by the single delta CT value of the housekeeping gene. 
(a), TNF superfamily member 10 relative gene expression, (nyoung = 16), (naged = 
19). (b), interferon-gamma relative gene expression, (nyoung = 11), (naged = 15). 
(c), colony-stimulating factor 1 relative gene expression, (nyoung = 12), (naged = 
17). (d) tumor necrosis factor relative gene expression, (nyoung = 9), (naged = 17). 
Data are mean ± SEM. A Student’s t-test was used to calculate the difference 
between the means.  
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3.4 Investigating white blood cell populations in young and aged 
mice.  
3.4.1 Confirmation of isolation of white blood cells  
A histological Giemsa stain was carried out on a white blood cell smear to confirm 
that the isolation of white blood cells was working. Figure 3.11 shows the Giemsa 
stain and subsequent cells present in the isolated white blood cell sample. The large, 
darkly stained blue cells are white blood cells (figure 3.11), which confirmed that our 





























Figure 3.11 Giemsa stained white blood cells from a white blood cell smear. The Black arrow is indicating a lymphocyte. Image was 
taken at 100x. 
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3.4.2 Spectral cytometry gating strategy  
Our gating strategy aimed to isolate all white blood cells and the subpopulations of 
interest, including T cells, T helper cells and T regulatory cells. A preliminary step 
was carried out to remove all cellular debris and red blood cells from the side and 
forward scattergram (figure 3.12a & c). All T cells and the subpopulations were gated 
using a fluorescence plot. Cells were identified positive for the antibody when they 
had high fluorescence. The quadrant gate was applied to our gating strategy as only 
two populations per sample were required to be identified. Two staining 
combinations were applied: first, samples identifying T cells and T helper cells, and 
secondly, samples identifying T helper cells and T regulatory cells.  
 
T cells and T helper cells were identified through the use of the CD3+ and the CD4+ 
antibodies. T cells were identified through high CD3+ fluorescence and low CD4+ 
fluorescence (figure 3.12b). T helper cells were identified through the high CD3+ and 
CD4+ fluorescence (figure 3.12b).  
 
T helper cells were identified in figure 3.12d by high CD4+ fluorescence and low 
Foxp3+ fluorescence (figure 3.12d). T regulatory cells were identified through high 
CD4+ and Foxp3+ fluorescence (figure 3.12d). 
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Figure 3.12 Spectral cytometry gating strategy. Scatter and fluorescence plots were 
produced using the Flow Jo version 10.0 programme. (a), represents the gating of 
white blood cells on a forward and side scatter plot for a sample stained for CD3+ 
and CD4+ cells. (b), represents the gating of CD3+ and CD4+ cells on a 
fluorescence plot. (c), represents the gating of white blood cells on a forward and 
side scatter plot for a sample stained for CD4+ and Foxp3+ cells. (d), represents the 




3.4.3 Quantified white blood cell populations  
Spectral cytometry was carried out to measure whether a change in the white blood 
cell population is present in young or aged mice. A dysregulation in the WBC 
populations involved in the response to pregnancy could explain the decrease in the 
survival of blastocysts in aged mice.   
 
Figure 3.13a exhibits the number of CD3+ T cells as a percentage of white blood cell 
cells. On average, 53.6% of the white blood cells were CD3+ T cells within the young 
samples (figure 3.13a). This number increased to 75.26% of white blood cells being 
CD3+ T cells in aged samples (figure 3.13a). There was no significant difference 
between the average percentage of CD3+ T cells within the white blood cell 
population in young and aged animals (P = 0.1537) (figure 3.13a).  
 
Figure 3.13b displays the number of CD4+ T helper cells as a percentage of the 
CD3+ T cells present. In young mice, 10.77% of CD3+ T cells were also marked with 
CD4+ (figure 3.13b). On average, 16.77% of the total T cells in aged mice were 
marked with CD4+ and acted as T helper cells (figure 3.13b). There was no 
significant difference between the percentage of CD4+ T helper cells in young and 
aged mice (P = 0.3292) (figure 3.13b).  
 
Figure 3.13c displays the percentages of Foxp3+ T regulatory cells relative to the 
total percentage of CD4+ T helper cells. T regulatory cells, on average, made up 
0.8151% of CD4+ T cells in young mice (figure 3.13c). In aged mice, 0.7788% of T 
helper cells were Foxp3+ T regulatory cells (figure 3.13c). No significant difference in 
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the number of T regulatory cells was identified between young and aged mice (figure 
3.13c).  
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Figure 3.13 White blood cell populations vital to the immune response during pregnancy. Data are mean ± SEM. (a), The CD3+ T 
cells as a percentage of white blood cells, (nyoung = 8), (naged = 7). (b), The of CD4+ T helper cells as a percentage of CD3+ T 
cells, (nyoung = 16), (naged = 15). (c), The Foxp3+ T regulatory cells as a percentage of CD4+ T helper cells, (nyoung = 8), (naged 
= 8). A Student’s t-test was used to calculate the difference between the means.  
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4 Discussion 
4.1 Summary  
The natural pregnancy model used in this study confirmed that preimplantation loss 
increases with advancing maternal age. Previously preimplantation loss has not 
been reported to significantly contribute to the age-related decline in fertility due to 
the inadequacies of the previous methods used to quantify the preimplantation loss. 
Our findings thus confirmed that mice are an appropriate model of the age-related 
decline in fertility.     
 
These experiments established that ovarian reserve exhaustion is not responsible for 
decreasing the number of embryos surviving to the blastocyst stage.  It was also 
confirmed that oviductal factors promoting or inhibiting embryonic growth do not 
change with age.  
 
This study illustrated that the dysregulation of the T cell population does not occur 
during the reproductive life span. Therefore, the inflammatory response to pregnancy 
is unlikely to be the cause of the age-related increase of preimplantation loss.    
4.2 The number of embryos surviving to the blastocyst stage 
decrease with advancing dam age  
Previous studies have reported no difference in the number of ovulations or time 
taken to mate with advancing maternal age (Harman & Talbert, 1970; Ishikawa & 
Yamauchi, 2003; Lopes et al., 2009). These studies complement our own, where we 
too identified no change in the number of ovulations or time taken to mate between 
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our young and aged mice. However, when considering the number of embryos that 
survive to the blastocyst stage, previous studies have reported no difference in the 
survival of embryos with advancing age. This has led to the long-term theory that the 
decline in fertility with increasing maternal age occurs post-implantation.  
 
An original study that influenced the theory that pregnancy loss occurs post-
implantation reported that young and aged CBA/H-T6 mice produced 76% and 74% 
blastocyst embryos on day 3.5 of pregnancy (Gosden, 1973). Thus no difference in 
the ability of an embryo to survive to the blastocyst stage was reported between 
young and aged mice (Gosden, 1973). The study concluded that preimplantation 
loss was insignificant, and the majority of embryo loss occurred post-implantation 
(Gosden, 1973). The percentage of blastocysts found in our study was significantly 
different than what was found in this historic study. Our study concluded that only 
57% of embryos survived to the blastocyst in aged mice compared to 84% in young 
mice. Therefore pre-implantation loss was significantly higher in aged animals in our 
study.  
 
The likely reason for the contradictory findings is a variation in methodology. 
Gosden. (1973) hyperstimulated young mice to induce oestrous cycling and promote 
ovulation (Gosden, 1973).  Hyperstimulation has been reported to decrease the 
quality and survival of preimplantation embryos (Sato & Marrs, 1986). Since this 
paper only hyperstimulated the young mice, it is possible that the difference in the 
preimplantation loss was concealed by decreasing the quality of young embryos. 
This may have resulted in the percentage of the blastocysts seen on day 3.5 of 
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pregnancy from the young animals appearing as low as the aged animals due to 
hyperstimulation decreasing the quality. Our study was strengthened using a natural 
pregnancy model, which allowed us to identify that preimplantation loss is 
significantly higher in aged mice.    
 
Another study reported no difference in the blastocyst recovery in Jcl/ICR mice aged 
9 to 11 and 13 to 15-month-olds (Ishikawa & Yamauchi, 2003). This paper concluded 
that there was no increase in preimplantation loss between middle-aged mice (9-11 
months old) and elderly mice (13-15 months old) (Ishikawa & Yamauchi, 2003). 
However, 9 to 11-month-old mice are at the end of their reproductive life span 
(Furuya et al., 2019). Therefore this paper compared two aged groups that rarely 
produce a litter. It is possible this study was unable to find a difference in the 
preimplantation loss within their populations due to their old ages. In contrast, our 
study used younger animals at the beginning and middle stages of their reproductive 
life span and compared this with mice at the end of their reproductive ability, which 
allowed us to identify the increase in preimplantation loss.  
 
The increase in preimplantation loss was identified in the IVCS strain of female mice, 
where aged mice on average produced significantly fewer blastocysts than young 
mice (Tappa et al., 1991). This finding agrees with our own. However, the paper then 
investigated post-implantation loss and reported a 100% incidence of post-
implantation loss within the aged mice (Tappa et al., 1991). The paper concluded 
that the age-related fertility decline of these mice was primarily due to post-
implantation effects (Tappa et al., 1991). In C57BL/6 mice, the foetal loss has been 
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reported to not occur until day 8, where higher rates of post-implantation loss are 
reported in aged females (Gosden et al., 1981).  
 
These historical publications have paved the way in how we study the age-related 
decline in fertility. For many years it has been reported that post-implantation effects 
are the sole cause of the fertility decline. A consequence of this is that most 
researchers now only consider post-implantation effects when investigating the 
decrease of fertility with advancing maternal age. This has resulted in minimal 
papers characterising natural in vivo preimplantation development and how this  
changes with increasing age (Ishikawa & Yamauchi, 2003; Tappa et al., 1991; 
Velazquez et al., 2016). It is surprising that the survival of embryos to the blastocyst 
stage in young and aged mice has not been looked into further. Especially 
considering if the historical findings are accurate, using mice as a model for the age-
related decline in fertility in humans would not be appropriate. As when females age, 
the percentage of preimplantation pregnancy loss increases (Velde, 2002).  
 
While this study was being undertaken, a paper was published investigating the 
effects of advanced maternal age on embryo development through culturing mouse 
embryonic-like stem cells from blastocysts to examine the percentage of aneuploidy 
present. Preliminary results concluded there was no difference in the number of 
degrading embryos at day 3.5 between 7 to 8 week old and 7 to 8-month-old mice 
(Khurana et al., 2021). This paper followed the same methodology as our study to 
mate and retrieve embryos at day 3.5 of pregnancy. However, they did not identify 
the same increase in preimplantation loss between young and aged C57BL/6  mice 
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that we did. This paper may not have identified the differences in the percentage of 
degrading embryos due to the age differences in the mice used. This study utilised 7 
to 8-month-old mice for their aged group while our study used 10 to 13 month-old 
mice. C57BL/6 mice have been reported to give birth to the largest litter sizes 
between 5-7 months old (Guo & Pankhurst, 2020). Therefore, the recent study may 
have needed to consider using older mice to accurately model the decrease in 
fertility. However, from this study’s results and our observation of preimplantation 
loss increasing in aged animals. We can confirm that in C57BL/6 mice, the increase 
in preimplantation loss does not happen until approximately 9-10 months of age.  
 
A restriction to our study is that we have only proven preimplantation loss to be 
significantly different with age in one strain of mice. The C57BL/6 strain and colony 
used in our study have previously been characterised as a model of age-related 
fertility decline. The litter size of the C57BL/6 mice appears to peak between 5 and 7 
months old (Guo & Pankhurst, 2020). After this peak, there is a decrease in litter 
size, with no pups being born after the dam reaches 12 months old (Guo & 
Pankhurst, 2020). Since we used a colony that was pre-determined to have a 
decrease in fertility with advancing age, it could be why we have identified a 
difference in embryos surviving to the blastocyst stage. However, the studies 
described above collectively failed to identify a difference in preimplantation loss 
when they quantified and staged the embryos approximately 3.5 days into pregnancy 
(Gosden, 1973; Ishikawa & Yamauchi, 2003; Khurana et al., 2021; Tappa et al., 
1991). In contrast, Gosden et al. (1981) did not consider pre-implantation loss as a 
factor (Gosden et al., 1981). However, the studies that failed to identify 
preimplantation loss or did not consider it did prove that post-implantation loss was 
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present with increasing age. (Gosden, 1973; Gosden et al., 1981; Ishikawa & 
Yamauchi, 2003; Khurana et al., 2021; Tappa et al., 1991). Therefore, it is unlikely 
that the decrease in blastocyst survival identified in our study was because we had 
previously characterised the reproductive decline in the colony. It is more likely that 
the increase in preimplantation loss was not previously reported due to the 
unsuitable methodology being used to quantify the loss.  
 
Within our study, embryos could have been lost or failed to develop at multiple 
stages of preimplantation development. This includes the oocyte not being ovulated 
from the corpora luteum, the oocyte not being fertilised, the oocyte being fertilised 
abnormally, the embryos being lost in transport between the oviduct and the uterus, 
and finally, the embryos not flushing out of the uteri correctly. This study is not able 
to confirm at which stage the embryos were lost. It was confirmed in this study that 
the number of corpora lutea remained the same independent of age, concluding that 
young and aged mice are ovulating the same number of eggs. Therefore, the 
difference in embryo survival to the blastocyst stage is not due to a change in 
ovulatory number. However, the study could not determine if the decrease in 
embryos surviving to the blastocyst stage was due to abnormal eggs leading to 
aneuploidy embryos or if the decrease occurred due to an oviductal environment 
factor affecting embryonic growth. 
 
While this study was undertaken, a different study investigating the effect of 
advanced maternal age on oocyte quality was published. This study reported that in 
4-month-old C57BL/6 mice, 20% of eggs are abnormal, while in 10-month-old mice, 
 81 
35% of eggs are abnormal (J. H. Lee et al., 2021). The difference in aneuploidy 
between a young and an aged mouse was reported as insignificant (J. H. Lee et al., 
2021). This concluded that abnormal eggs are unlikely to cause the decrease in 
blastocyst survival in aged mice as there is no difference in the percentage of 
abnormal eggs with advancing maternal age. Spontaneous aneuploidy in mice has 
been reported to be an inappropriate model for aneuploidy in humans since the 
percentage of aneuploidy in mice is lower than humans (Bond et al., 1983). 
However, the current reports of a low percentage of aneuploidy in aged mice support 
our hypothesis that another contributing factor must be present to decrease the 
number of embryos surviving to the blastocyst stage in aged animals.     
 
Our modern-day study has proven that mice are an appropriate model for the age-
related decline of fertility and show a significant decrease in fertility that affects 
preimplantation development, which has previously been overlooked.    
4.3 Communication from the oviduct derived growth factors to the 
embryo and their relationship with age 
Communication between the oviduct and embryo is necessary during pregnancy to 
regulate the growth of the embryo. This communication occurs through growth-
inhibiting and promoting factors that are inflammatory cytokines. The development of 
the oviduct and embryo co-culture experiments included in this study confirmed the 
presence of communication. This was seen through the anatomy of the ampulla. 
When the embryos were alive, the ampulla would remain fluid-filled. However, if the 
embryos had degraded, the ampulla did collapse in on itself. While we do not know 
what caused the fluid-filled characteristic, we confirmed that a communication 
mechanism was occurring between embryos that were alive and the oviduct. 
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The current literature investigating the effect of advanced maternal age on 
communication through growth factors present within the oviduct is minimal. The 
majority of the literature concerning growth factors that promote or inhibit growth is 
centred on the uterus. Studies have reported an increased level of EGF, PDGFA, 
CSF-1, and IGF-1 in the uterus at the time of implantation to promote proliferation, 
adhesion, and invasion of the embryo (De et al., 1993; Haimovici & Anderson, 1993; 
Hunt, 1989). There have also been reports that decidual cells of the uterus produce 
an increased percentage of inhibitory proteins at the time of implantation, including 
TNF, to mediate the invasion of the embryo (Bauer et al., 2004). 
 
Only one known paper has investigated the age dependant changes of growth 
factors within the bovine species. This paper identified upregulation of growth-
inhibiting factors, including TNF, in aged bovine oviduct epithelial cells (Tanaka et 
al., 2014). Tanaka et al. (2014) use of cultured cells may have limited this study. 
Cultured cells act differently than in vivo cells and thus do not usually make a good 
model for what is occurring in vivo. The cells also had to be physically detached from 
the oviducts for culture. This may have caused an inflammatory response to be 
activated from the manipulation and could change the presence of pro-inflammatory 
cytokines within the cells analyzed. This physical manipulation may explain why this 
study identified an upregulation of pro-inflammatory cytokines in aged mice and why 
our study did not identify the same upregulation.   
 
Our study did not identify any difference in growth-promoting or inhibiting factors 
between young and aged mice within the oviducts. Our RT-qPCR results produced a 
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high variation. However, due to the limited literature published concerning the 
oviduct RNA and the corresponding growth factors of interest, there is a possibility 
that this variation is normal for oviducts. A previous study within our lab extracted 
RNA from the oviducts with the same methodology but did not use RNA later 
(Sanders, 2015). The experiment was used to confirm if the growth factors measured 
in our study were present in the oviduct (Sanders, 2015). While they did report the 
presence of the growth factors, there was variation within the samples (Sanders, 
2015). The thesis suggested using RNA later to avoid RNA degradation by reducing 
the time between tissue collection and freezing before the RNA is preserved 
(Sanders, 2015). Since RNA later did not appear to fix the variation within our 
samples, the variation is likely natural for oviducts. The variation was also reported to 
be the same across all samples in our study. This was confirmed through 
Kolmogorov-Smirnov tests. Therefore, the variation within this data set is not a 
weakness and is likely a result of biological variation.     
 
A recent review has suggested that embryo-maternal crosstalk is site-specific within 
the oviduct. This suggests that there is unlikely to be any communication via growth-
promoting or inhibiting factors within the isthmus of the oviduct, as the role of the 
isthmus is primarily transport; instead, communication occurs at the ampulla (Kölle et 
al., 2020). This proposes a limitation of our study, as we measured RNA from the 
entire oviduct instead of the ampulla alone (Kölle et al., 2020). It is possible that if we 
measured RNA from the ampulla alone, we might have identified a difference in 
growth-promoting or inhibiting factors between young and aged animals. However, 
this does propose technical issues, as the amount of RNA extracted from an entire 
oviduct is low. Decreasing the tissue size to the ampulla alone would introduce 
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further limitations such as RNA degradation (Triant & Whitehead, 2009). RNA is 
inherently unstable and begins degrading immediately after death, especially when 
exposed to room temperature. It would take more time to dissect out the ampulla 
only and freeze the tissue to -80˚C degrees. Thus introducing more time for 
endogenous RNAses to degrade the RNA. In this study, we used RNA later to avoid 
RNA degradation while the tissue was exposed during the dissection. However, a 
previous study has shown that usable RNA was collected from small tissue samples 
only when treated with RNAlater and snap frozen at -80˚C degrees (Micke et al., 
2006). If we had used RNAlater in conjunction with snap freezing, the variation of the 
RNA samples seen in our study might have decreased. This should be considered in 
future experiments undertaking RNA extraction on the ampulla to investigate the 
growth factors present.  
 
This study confirmed no difference within growth-promoting or inhibiting factors 
between the young and aged mice oviducts. Thus, communication during early 
pregnancy is not affected in the aged oviduct and is not why the embryos surviving 
to the blastocyst stage are decreased in aged mice. 
4.4 The maternal inflammation response to pregnancy 
 
Pregnancy is mediated by the maternal inflammation response. Successful 
pregnancy requires branches of the inflammatory system to work together to silence 
and upregulate each other to promote embryonic growth and implantation. The 
significant leukocyte population in the maintenance of pregnancy are the T cells. 
CD3+ T cells and CD4+ T helper cells are essential for pregnancy as they mediate 
maternal and embryonic communication. T cells and T helper cells express 
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inflammatory cytokines that are growth promoters and growth inhibitors within the 
maternal environment.  
 
It has been reported that the expression of the T cell receptor in the peripheral 
tolerance of mice aged 12 to 15 months does not change when compared to 
younger mice of the same strain (Callahan et al., 1993; Freitas & Rocha, 2000; Surh 
& Sprent, 2002). However, in C57BL/6 mice, the percentage of CD4+ T helper cells 
within the blood in 14 to 15-month old mice was reported to be significantly lower 
compared to 4-month-old mice (Oughton et al., 1995). There is conflicting 
information on whether or not there are changes within T cell populations in the 
aging process. These contradictions appear to be due to strain differences. It has 
been proven that mice undergo thymic involution at different times, suggesting that 
different strains of mice experience aging of the immune system at different time 
points (Hsu et al., 2003). Therefore the age and species at which a dysregulation in 
T cell populations occurs will affect whether a study can identify the significant 
difference between young and aged mice.  
 
At conception, the maternal inflammation system must turn on the Treg cells to 
silence the inflammation response against the paternal alloantigen’s. Previous 
studies have reported that the number of Treg cells in the spleen and lymph nodes 
increase with age but do not increase in the blood (Chiu et al., 2007; Lages et al., 
2008; Raynor et al., 2013; Sharma et al., 2006). However, a study in 20-month-old 




Our study identified no significant difference in T cell, T helper cell or, Treg cell 
populations between young and aged C57BL/6 mice. While previous studies have 
identified a decrease in CD4+ T helper cells and an increase of Foxp3+ Treg cells 
within the blood, the difference was likely identified as these studies used mice older 
than 14 months of age (Oughton et al., 1995; Zhao et al., 2007a). It appears this 
dysregulation of T helper and T regulatory cells is occurring in the post-ovulatory 
phases of the mouse reproductive life span. This is important to characterise to 
understand the effect of aging on the immune system. However, in our study it does 
not provide any relevance as at this point in the mice’s life, they will be experiencing 
ovarian reserve exhaustion and will no longer be ovulating (Guo & Pankhurst, 2020). 
 
The majority of the literature concerning when chronic inflammation begins in aged 
mice is undertaken in 20 to 24-month-old mice (Bryant et al., 2019; Wong et al., 
2013). This suggests that the long-term inflammation associated with chronic 
inflammation does not ensue until well after the reproductive phase of a mouse’s life 
ends. Therefore, this describes that no difference is likely seen in the total T cell 
populations within the blood while a mouse is aged 10-12 months as chronic 
inflammation has not occurred yet. Thus, the change in white blood cells will not 
explain why there is a decrease in blastocyst survival in aged mice compared to 
young mice.  
 
Another theory describing how Treg cells may contribute to the decrease in embryo 
survival to the blastocyst stage is that Treg function decreases with advancing age. 
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The transfer of Treg cells derived from 20-month-old mice into 3-month-old mice 
exhibited a lower suppression ability than the young Treg cells (Zhao et al., 2007). A 
secondary study also reported that Treg cells from 20-month-old mice inhibit the 
expression IL-17 of T cells less efficiently than Treg cells from young mice (Lages et 
al., 2008). While interesting, these studies were also completed in aged mice who 
have surpassed their ability to produce offspring. Therefore, the decrease in function 
of Treg cells subsequently resulting in the activation of the maternal inflammatory 
response against the foreign embryo is unlikely to explain why a decrease in the 
survivability of blastocysts was seen in our study. This is due to the function of the 
Treg cells only degrading in post-ovulatory aged mice.  
 
The literature surrounding the change in T cell, T helper cell, and Treg cell 
populations and the age-related change within these populations is ambiguous. Our 
data has contributed to this field of research as the age-related change has not been 
considered in aged mice that are still reproductively active. We confirmed no 
significant difference in the number of T cell, T helper cell, or Treg cell populations 
when comparing C57BL/6 mice aged 4-6 months and 10-13 months old.  
4.5 Strengths and limitations of this model  
Previously the oviduct has not been considered as a possible contributor to the age-
related decline in fertility. This is mainly due to IVF eliminating the role of the oviduct; 
since IVF has proven to be successful, it was assumed that the oviduct is not 
essential for pregnancy. Our natural pregnancy model has confirmed that the 
decrease in fertility seen in aged mice is not due to a lack of oocytes in the ovary, as 
previously believed. This study’s main limitation is that we cannot determine whether 
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the decrease in blastocyst survival is due to the increase in aneuploidy eggs in the 
aged ovary or a maternal environmental factor within the oviduct that affects the 
embryo development. Due to the cancelling of the in-situ cultures, this study can only 
correlate a possible age related oviductal effect and the decrease in survival of 
embryos to the blastocyst stage. However, this study was based on strong biological 
plausibility and was strengthened by the large sample sizes. Through the cancelling 
of the cultures, we strengthened the association seen in the increase in pre-
implantation loss in aged mice. We also ruled out the possibility of ovarian reserve 
exhaustion being the cause of the age-related decline in fertility.  
4.6 Future directions 
This study revealed that the decrease in fertility in aged animals might be due to an 
increased number of abnormal oocytes or an oviduct-derived factor negatively 
affecting embryogenesis. Since the natural pregnancy model was used, we can now 
complete a more straightforward culture than the oviduct embryo co-culture designed 
to confirm if the oviduct is a factor within the age-related decline in fertility. To do 
this, we would need to eliminate the influence the oviduct has on the growth of the 
embryos in the first days of embryogenesis through the growth-promoting and 
growth-inhibiting factors. Completing the embryo in vitro cultures as described in 
chapter 2 would remove all oviduct growth factors and environmental factors 
influencing embryo growth. This would allow us to determine the percentage of 
embryos surviving to the blastocyst stage in an environment with no maternal 
influences. We could then compare the percentage of loss from the embryo in vitro 
culture to the loss seen in our study’s preimplantation natural pregnancy model. This 
would confirm if the oviducts contributed to the age-related decline in fertility or if all 
preimplantation loss is due to increased abnormal oocytes in the ovary.  
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Follow-up experiments investigating the presence of growth promoters and inhibitors 
in young and aged ampullae would be beneficial to carry out. This could also be 
completed on oviductal fluid; however, a different animal model, such as the sheep 
or cow, may need to be considered due to the small size of the murine oviduct and 
low volume of fluid that could be collected. It would also be worth carrying out shot-
gun proteomics to see if the levels of growth-promoting and inhibiting factors change 
due to the dysregulation of protein folding and stability of an aged mouse. It has 
previously been reported that protein folding and stability are affected by advancing 
age (Roberts et al., 2016). Therefore the change in communication within the oviduct 
may not be occurring at the mRNA level but at the protein level.  
 
Due to the lack of experiments completed on reproductive-aged mice Treg cell 
functions, I suggest carrying out functional marker tests on aged mice that can still 
produce offspring. Functional markers that could be tested include TNFR2, CD25, 
and ICOS (Chen & Oppenheim, 2011). If a difference in functional Treg cell markers 
is determined between young and aged, pregnant mice, it would be beneficial to 
confirm causation. This could be completed by using an antibody-drug such as anti-
CD25 mAb that will knock down the effect of Treg cells in both young and aged mice 
to model the preimplantation loss of embryos (Shima et al., 2010).  
4.7 Conclusions  
The experiments from this study have proven that preimplantation loss is increased 
in 10 to 13-month-old mice compared to 4 to 6-month-old mice. Therefore, this 
confirmed that mice are a good model for investigating the reproductive decline 
occurring with advanced maternal age. This study confirmed that the decrease of 
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embryos surviving to the blastocyst stage was not due to ovarian reserve depletion 
in the aged mice. Therefore, the age-related reproductive decline in these mice is 
due to a post-ovulatory effect such as an increase in abnormal oocytes ovulated or 
the aged oviduct having a negative effect on embryo development.  
 
This study confirmed that the decreased survival of embryos to the blastocyst stage 
is not due to the change in growth-promoting or growth-inhibiting factors in the aged 
oviduct. It was also deduced that this decrease was not due to the change in T cell 
populations affecting the inflammatory response to pregnancy.  
 
Currently, the cause of the decrease in fertility with advancing maternal age remains 
ambiguous. Our study has answered three previously unanswered questions and 
has aided in ruling out possible contributors to the age-related decline in fertility. We 
now know that mice experience increased preimplantation loss due to a post-
ovulatory effect that is not related to the oviduct-derived growth factors or T cell 
population changes. Ruling out these possibilities has increased and widened the 
knowledge that we currently have concerning the aging oviduct. 
 
Based on these findings, it is likely that the oviduct is not contributing to the age-
related decline in fertility. We suggest that the age related-decrease in fertility is 
likely due to an increase in abnormal oocytes within the aged ovary that has 
previously been underestimated in the literature. The oviduct may also contribute to 
the decline observed. However, further studies must be undertaken to confirm this.  
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Our study has contributed to the limited literature on the oviduct’s role in the age-
related decline in female fertility. These results provide preliminary conclusions that 
can be confirmed and investigated in subsequent studies. 
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